A Case Series of α-Thalassemia Intermedia Due to Compound Heterozygosity for Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] With Other α-Thalassemias in Malay Families

References

• Bain BJ. Haemoglobinopathy Diagnosis, 2nd ed. Oxford: Blackwell Publishing Ltd., 2006
   Google Scholar
• Liebhaber SA, Cash FE, Ballas SK. Human α-globin gene expression. The dominant role of the α2-locus in mRNA and protein synthesis. J Biol Chem. 1986;261(32):15327–15333
   PubMed Web of Science ®Google Scholar
• Viprakasit V, Tanphaichitr VS, Pung-Amritt P, et al. Clinical phenotypes and molecular characterization of Hb H-Paksé disease. Haematologica. 2002;87(2):117–125
   PubMed Web of Science ®Google Scholar
• Chui DHK, Fucharoen S, Chan V. Hemoglobin H disease: Not necessarily a benign disorder. Blood. 2003;101(3):791–800
   PubMed Web of Science ®Google Scholar
• Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of Haemoglobin H disease: A Greek experience. Br J Haematol. 2000;111(3):915–923
   PubMed Web of Science ®Google Scholar
• Çürük MA, Dimovski AJ, Baysal E, et al. Hb Adana, a severely unstable α1 globin gene variant, observed in combination with the –(α)20.5kb α-thal-1 deletion in two Turkish patients. Am J Hematol. 1993;44(4):270–275
   PubMed Web of Science ®Google Scholar
• Nainggolan IM, Harahap A, Setianingsih I. Hydrops fetalis associated with homozygosity for Hb Adana. Hemoglobin. 2010;34(4):394–401
   PubMed Web of Science ®Google Scholar
• George E, Jama T, Azian AS, et al. A rare case of α-thalassaemia intermedia in a Malay patient double heterozygous for α+-thalassaemia and a mutation in α1 globin gene CD59 (GGCGAC). Med J Malaysia. 2009;64(4):321–322
   PubMedGoogle Scholar
• Setianingsih I, Harahap A, Nainggolan IM. α Thalassaemia in Indonesia: Phenotypes and molecular defects. Adv Exp Med Biol. 2003;531:47–56
   PubMed Web of Science ®Google Scholar
• Higgs DR. α-Thalassaemia. In: Higgs DR, Weatherall DJ, Eds. The Haemoglobinopathies. Bailliére’s Clinical Haematology, Vol. 6. London: W.B Saunders Company. 1993:117–150
   Google Scholar
• Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–362
   PubMed Web of Science ®Google Scholar
• Eng B, Patterson M, Walker L, et al. Detection of severe nondeletional α-thalassemia mutations using a single-tube multiplex ARMS assay. Genet Test. 2001;5(4):327–329
   PubMedGoogle Scholar
• Winterbourn CC, Williamson D, Vissers MCM, Carrell RW. Unstable haemoglobin haemolytic crises: Contributions of pyrexia and neutrophil oxidants. Br J Haematol. 1981;49(1):111–116
   PubMedGoogle Scholar
• Pootrakul P, Sirankapracha P, Hemsorach S, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia. Blood. 2000;96(7):2606–2612
   PubMed Web of Science ®Google Scholar
• Schrier SL, Rachmilewitz E, Mohandas N. Cellular and membrane properties of α and β thalassemic erythrocytes are different: implication for differences in clinical manifestations. Blood. 1989;74(6):2194–2202
   PubMed Web of Science ®Google Scholar
• Liebhaber SA, Schrier SL. Pathophysiology of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press. 2001:391–404
   Google Scholar
• Pootrakul P, Winichagoon P, Fucharoen S, et al. Homozygous Constant Spring: A need for revision of concept. Hum Genet. 1981;59(3):250–255
   PubMed Web of Science ®Google Scholar
• Douna V, Papassotiriou I, Garoufi A, et al. A rare thalassemic syndrome caused by interaction of Hb Adana [α59(E8)Gly→Asp] with an α+-thalassemia deletion: Clinical aspects in two cases. Hemoglobin. 2008;32(4):361–369
   PubMed Web of Science ®Google Scholar
• Traeger-Synodinos J, Metaxotou-Mavrommati A, Karagiorga M, et al. Interaction of an α+-thalassemia deletion with either a highly unstable α-globin variant (α2, codon 59, GGC→GAC) or a nondeletional α-thalassemia mutation (AATAAA→AATAAG): Comparison of phenotypes illustrating “dominant” α-thalassemia. Hemoglobin. 1999;23(4):325–337
   PubMed Web of Science ®Google Scholar
• Henderson S, Pitman M, McCarthy J, et al. Molecular prenatal diagnosis of Hb H hydrops fetalis caused by Hemoglobin Adana and the implications to antenatal screening for α-thalassemia. Prenat Diagn. 2008;28(9):859–861
   PubMed Web of Science ®Google Scholar
• Fucharoen S, Viprakasit V. Hb H disease: Clinical course and disease modifiers. Hematol Am Soc Hematol Educ Program. 2009:26–34. doi: 10.1182/asheducation-2009.1–26
   PubMedGoogle Scholar
• Borgna-Pignatti C. Modern treatment of thalassaemia intermedia. Br J Haematol. 2007;138(3):291–304
   PubMed Web of Science ®Google Scholar
• Taher A, Isma’eel H, Cappellini MD. Thalassemia intermedia revisited. Blood Cells Mol Dis. 2006;37(1):12–20
   PubMed Web of Science ®Google Scholar
• Weatherall DJ. Phenotype-genotype relationship in monogenic disease: Lessons from the thalassaemias. Nat Rev Genet. 2001;2(4):245–255
   PubMed Web of Science ®Google Scholar